Status:
COMPLETED
Microbiome and Volatile Organic Compounds in Patients With CDH
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
University of Rostock
Conditions:
Congenital Diaphragmatic Hernia
Eligibility:
All Genders
6-16 years
Phase:
NA
Brief Summary
Despite improved prenatal diagnostics and therapeutic possibilities, congenital diaphragmatic hernia (CDH) represents a cross-disciplinary challenge. With an incidence of 1:2000-1:5000, it is a common...
Detailed Description
Aim: The aim of this study is to evaluate children who have been enrolled on the basis of a hernia, the pulmonary microbiome and the volatile organic compounds (VOCs) in the exhaled air and to compare...
Eligibility Criteria
Inclusion
- Age from 6-16 years
- Age 0-6 months at time of CDH-OP (except control group)
- reliable diagnosis of congenital diaphragmatic hernia (except control group)
- surgical occlusion with patch (except control group)
- surgical occlusion without patch (except control group)
- given approval
Exclusion
- chronic pulmonary diseases
- Infection within 4 weeks before the test date
- unaccepted consent
Key Trial Info
Start Date :
March 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03787160
Start Date
March 22 2018
End Date
October 1 2019
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Department of Pediatric and Adolescent Surgery, Medical University of Graz
Graz, Styria, Austria, 8036